Data protection Impressum

Imaging

Ikerian AG, along with its subsidiary RetinAI, has successfully completed a USD 6.18 million Series A extension financing round to propel the development and commercial rollout of innovative medical technologies.

Ikerian, parent company of RetinAI, secures USD 6.18 million for AI-driven medical advancements

13 May 2024

RetinAI partners with Boehringer Ingelheim to improve retinal disease treatment

26 April 2023

CSEM start-up MATIS to revolutionize the authentication of works of art

5 October 2022

Precision agriculture startup Gamaya raises CHF 12 million

24 July 2019

Bracco invests 60 million euros in Geneva

1 July 2019

Bern start-up RetinAI raises CHF 2.3 million

12 June 2019

1 2